Simon Stroebel, PhD

Simon Stroebel, PhD has extensive work experience in the field of research and development. Simon began their career at the University of Basel, where they completed their PhD from June 2003 to July 2007. Following this, Simon worked as a Postdoc at the University Hospital Basel from July 2007 to May 2008. Simon then joined the University of Otago as a Postdoc from June 2008 to April 2010.

In 2010, Simon transitioned to industry and joined InSphero as a Senior Research Scientist. Simon held this position until January 2016, during which they made significant contributions to the company's research and development efforts. Simon then took on the role of Product Manager at InSphero from February 2016 to December 2017, further showcasing their ability to drive projects and oversee product development.

Currently, Simon is working as a Senior Scientist and Team Lead for R&D Liver Disease at InSphero, a position they have held since December 2017. In this role, they bring their expertise in liver disease research and leads a team in developing innovative solutions.

Overall, Simon Stroebel, PhD has a strong track record in the research and development field, with experience in academia as well as in industry. Simon has consistently demonstrated their ability to contribute to scientific advancements and take on leadership roles.

Simon Stroebel, PhD has a diverse education background in the field of biomedical engineering and pharmaceutical sciences. Simon completed their PhD in Biomedical Engineering at the University of Basel from 2003 to 2007. Prior to their PhD, Simon obtained a Masters of Science (MSc) in Molecular and Cell Biology from the University of Basel, which they completed from 1997 to 2002.

Following their PhD, Simon pursued a postdoctoral fellowship in Biomedical Engineering at the University of Basel, which they completed from 2007 to 2008. Additionally, they participated in a trainee program at Novartis Pharma from 2002 to 2003.

Furthermore, Simon acquired a Certificate of Advanced Studies (CAS) in Pharmaceutical Sciences from ETH Zürich, which they completed in 2022.

No information is available regarding Simon's education before their MSc in Molecular and Cell Biology at the University of Basel.